|
|
(12 intermediate revisions not shown) |
Line 11: |
Line 11: |
| <div> | | <div> |
| <ul class="nav-list" id="lab-list"> | | <ul class="nav-list" id="lab-list"> |
- | <li><a href="/Team:Hong_Kong-CUHK/Safety" style="background:#95DC19;">Safety</a></li> | + | <li><a href="/Team:Hong_Kong-CUHK/Notebook">Note Book</a></li> |
- | <li><a href="/Team:Hong_Kong-CUHK/Laboratory_log_book" style="color:black;">log book</a></li>
| + | <li><a href="/Team:Hong_Kong-CUHK/Laboratory/protocol">Protocol</a></li> |
- | <li><a id="Collaboration">Collaboration</a></li> | + | |
- | <li><a id="Biobricks">Biobricks construct</a></li> | + | |
- | </ul>
| + | <li><a href="/Team:Hong_Kong-CUHK/Laboratory/collaboration" id="Collaboration">Collaboration</a></li> |
| + | <li><a href="/Team:Hong_Kong-CUHK/Laboratory/biobricks" id="Biobricks">Biobricks Construct</a></li> </ul> |
| </div> | | </div> |
| | | |
Line 22: |
Line 23: |
| <div class="span-17 last" id="lab-target"> | | <div class="span-17 last" id="lab-target"> |
| </div> | | </div> |
- |
| |
- | <div style="display:none">
| |
- | <div id="Collaboration">
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p>
| |
- | <strong>Collaboration</strong>
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p>
| |
- | We are glad to cooperate with HKUST-Hong_Kong onmodeling the hypothetical behavior of bcr gene induced by lac or T7. bcr is amembrane protein that actively pumps out a variety of substrates from the cell,notably antibiotics such as tetracycline and kanamycin. Hence, expression ofbcr leads to antibiotic resistance. The collaboration was established becauseof the similarity between halorhodopsin and bcr. Both proteins are membranetransporters, and we are familiar with such scenario.
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p>
| |
- | Minimum Inhibitory Concentration (MIC) is acommonly-used indicator to measure the vulnerability of bacteria in presence ofantibiotics. It is usually determined by the minimum concentration ofantibiotics that could cause observable reduction in turbidity and/or opticaldensity for an overnight LB culture. We modeled the relationship between thechange of MIC of tetracycline and kanamycin respectively and the concentrationof IPTG, which induces bcr downstream of P<sub>lac</sub> in <em>E. coli</em>. The change of MIC is reported asthe ratio of the MIC of bcr-transformed <em>E.coli</em> over that of wildtype <em>E. coli</em>.
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p>
| |
- | <strong>Modelingresults</strong>
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p>
| |
- | We modeled HKUST’s data with three assumptions.Firstly, antibiotics are applied during exponential phase or stationary phase.Secondly, P<sub>lac</sub> only affects the expression of target genes (bcr).Finally, IPTG doesn’t affect other metabolic pathways except P<sub>lac</sub>induction. We modeled the activity of P<sub>lac</sub> under different IPTG concentrations(Fig. 1) and the relationship between the activity of native promoter of bcrand the MIC change (Fig. 2). Then we achieved our goal to show the effect ofIPTG concentration on the change of MIC by combining the P<sub>lac</sub>activity and the MIC change of wild type bcr (Fig. 3). We discovered that onlya small amount of IPTG is essential to induce bcr and trigger similarantibiotic resistance compared with wild type. However, further increase ofIPTG concentration has limited effect on strengthening antibiotic resistance.This is probably due to the saturation of IPTG in bcr induction where the bcramount reaches the peak, while the concentration of antibiotics keepsincreasing.
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p>
| |
- | References
| |
- | </p>
| |
- | <p>
| |
- | [1] RegulonDB
| |
- | </p>
| |
- | <p>
| |
- | http://regulondb.ccg.unam.mx/operon?term=ECK120014773&format=jsp#myReferences
| |
- | </p>
| |
- | <p>
| |
- | [2] Increased expression of the multidrug effluxgenes acrAB occurs during slow growth of Escherichia coli FEMS MicrobiologyLetters Volume 207, Issue 1, pages 91–95, January 2002
| |
- | </p>
| |
- | <p>
| |
- | [3] http://www.expressys.com/main_applications.html
| |
- | </p>
| |
- | <p>
| |
- | [4] http://partsregistry.org/Part:BBa_R0010:Experience
| |
- | </p>
| |
- | <p>
| |
- | [5] Analysis of a Complete Library of Putative DrugTransporter Genes in Escherichia coli J Bacteriol. 2001 October; 183(20):5803–5812.
| |
- | </p>
| |
- | <p>
| |
- | [6] https://2011.igem.org/Team:TU_Munich/lab/results
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <br />
| |
- | </div>
| |
- |
| |
- | <div id="Biobricks">
| |
- | <p>
| |
- | Field: Laboratory
| |
- | </p>
| |
- | <p>
| |
- | Block: Biobricks construct
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p>
| |
- | <strong>Biobricksconstruct</strong>
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p>
| |
- | 1. Halorhodopsin(BBa_K559000)
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p align="center">
| |
- |
| |
- | </p>
| |
- | <p>
| |
- | 2. Halorhodopsinunder T7 promoter (BBa_K590001)
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
- | <p align="center">
| |
- |
| |
- | </p>
| |
- | <p>
| |
- | 3. Halorhodopsincomplete system (BBa_559010)
| |
- | </p>
| |
- | <p>
| |
- |
| |
- | </p>
| |
| | | |
- | </div>
| |
| </div> | | </div> |
- |
| |
- | </div>
| |
- |
| |
- | <script type="text/javascript">
| |
- | $('ul#lab-list li a').click(function() {
| |
- | $("div#lab-target").html($('div#'+$(this).attr('id')).html());
| |
- | });
| |
- | </script>
| |
| | | |
| </html> | | </html> |
| + | {{Template:Team:Hong_Kong-CUHK/TEMPLATE_2011_FOOT}} |